O	0	6	Impact	Impact	NN	B-NP
O	7	9	of	of	IN	B-PP
O	10	23	dexamethasone	dexamethasone	NN	B-NP
O	23	24	-	-	HYPH	B-NP
O	24	31	induced	induce	VBN	I-NP
O	32	49	immunosuppression	immunosuppression	NN	I-NP
O	50	52	on	on	IN	B-PP
O	53	56	the	the	DT	B-NP
O	57	65	duration	duration	NN	I-NP
O	66	69	and	and	CC	I-NP
O	70	75	level	level	NN	I-NP
O	76	78	of	of	IN	B-PP
O	79	87	shedding	shedding	NN	B-NP
O	88	90	of	of	IN	B-PP
O	91	102	Escherichia	Escherichia	FW	B-NP
O	103	107	coli	coli	FW	I-NP
O	108	112	O157	O157	NN	I-NP
O	112	113	:	:	:	O
O	113	115	H7	H7	NN	B-NP
O	116	118	in	in	IN	B-PP
O	119	125	calves	calf	NNS	B-NP
O	125	126	.	.	.	O

O	127	130	The	The	DT	B-NP
O	131	135	goal	goal	NN	I-NP
O	136	138	of	of	IN	B-PP
O	139	143	this	this	DT	B-NP
O	144	149	study	study	NN	I-NP
O	150	153	was	be	VBD	B-VP
O	154	156	to	to	TO	B-VP
O	157	166	determine	determine	VB	I-VP
O	167	174	whether	whether	IN	B-SBAR
O	175	192	immunosuppression	immunosuppression	NN	B-NP
O	193	198	plays	play	VBZ	B-VP
O	199	200	a	a	DT	B-NP
O	201	205	role	role	NN	I-NP
O	206	208	in	in	IN	B-PP
O	209	212	the	the	DT	B-NP
O	213	218	level	level	NN	I-NP
O	219	222	and	and	CC	I-NP
O	223	231	duration	duration	NN	I-NP
O	232	234	of	of	IN	B-PP
B-Organism_substance	235	240	fecal	fecal	JJ	B-NP
O	241	249	shedding	shedding	NN	I-NP
O	250	252	of	of	IN	B-PP
O	253	264	Escherichia	Escherichia	FW	B-NP
O	265	269	coli	coli	FW	I-NP
O	270	274	O157	O157	NN	I-NP
O	274	275	.	.	.	O

O	276	293	Immunosuppression	Immunosuppression	NN	B-NP
O	294	297	was	be	VBD	B-VP
O	298	305	induced	induce	VBN	I-VP
O	306	308	in	in	IN	B-PP
O	309	315	calves	calf	NNS	B-NP
O	316	318	by	by	IN	B-PP
O	319	332	administering	administer	VBG	B-VP
O	333	346	dexamethasone	dexamethasone	NN	B-NP
O	346	347	.	.	.	O

O	348	351	Six	Six	CD	B-NP
O	352	353	1	1	CD	I-NP
O	353	354	-	-	HYPH	B-NP
O	354	358	week	week	NN	I-NP
O	358	359	-	-	HYPH	O
O	359	362	old	old	JJ	B-NP
O	363	371	Holstein	Holstein	NN	I-NP
O	372	376	bull	bull	NN	I-NP
O	377	383	calves	calf	NNS	I-NP
O	384	388	were	be	VBD	B-VP
O	389	397	injected	inject	VBN	I-VP
B-Immaterial_anatomical_entity	398	413	intramuscularly	intramuscularly	RB	B-ADVP
O	414	418	with	with	IN	B-PP
O	419	432	dexamethasone	dexamethasone	NN	B-NP
O	433	436	and	and	CC	O
B-Organism_subdivision	437	443	orally	orally	RB	B-VP
O	444	454	inoculated	inoculate	VBN	I-VP
O	455	459	with	with	IN	B-PP
O	460	462	10	10	CD	B-NP
O	462	463	(	(	(	O
O	463	464	9	9	CD	B-NP
O	464	465	)	)	)	O
O	466	469	CFU	CFU	NN	B-NP
O	470	472	of	of	IN	B-PP
O	473	474	a	a	DT	B-NP
O	475	482	mixture	mixture	NN	I-NP
O	483	485	of	of	IN	B-PP
O	486	491	three	three	CD	B-NP
O	492	501	nalidixic	nalidixic	JJ	I-NP
O	501	502	-	-	HYPH	I-NP
O	502	506	acid	acid	NN	I-NP
O	507	516	resistant	resistant	JJ	I-NP
B-Cell	517	524	strains	strain	NNS	I-NP
O	525	527	of	of	IN	B-PP
O	528	529	E	E	NN	B-NP
O	529	530	.	.	.	O
O	531	535	coli	coli	NN	B-NP
O	536	540	O157	O157	NN	I-NP
O	540	541	:	:	:	O
O	541	543	H7	H7	NN	B-NP
O	543	544	.	.	.	O

O	545	549	Five	Five	CD	B-NP
O	550	551	1	1	CD	I-NP
O	551	552	-	-	HYPH	B-NP
O	552	556	week	week	NN	I-NP
O	556	557	-	-	HYPH	O
O	557	560	old	old	JJ	B-NP
O	561	569	Holstein	Holstein	NN	I-NP
O	570	574	bull	bull	NN	I-NP
O	575	581	calves	calf	NNS	I-NP
O	582	586	that	that	WDT	B-NP
O	587	591	were	be	VBD	B-VP
O	592	597	given	give	VBN	I-VP
O	598	601	the	the	DT	B-NP
O	602	606	same	same	JJ	I-NP
B-Organism_subdivision	607	611	oral	oral	JJ	I-NP
O	612	623	inoculation	inoculation	NN	I-NP
O	624	626	of	of	IN	B-PP
O	627	628	E	E	NN	B-NP
O	628	629	.	.	.	O
O	630	634	coli	coli	NN	B-NP
O	635	639	O157	O157	NN	I-NP
O	639	640	:	:	:	O
O	640	642	H7	H7	NN	B-NP
O	642	643	,	,	,	O
O	644	647	but	but	CC	B-CONJP
O	648	651	not	not	RB	I-CONJP
O	652	655	the	the	DT	B-NP
O	656	669	dexamethasone	dexamethasone	NN	I-NP
O	670	680	injections	injection	NNS	I-NP
O	680	681	,	,	,	O
O	682	688	served	serve	VBD	B-VP
O	689	691	as	as	IN	B-PP
O	692	700	controls	control	NNS	B-NP
O	700	701	.	.	.	O

O	702	705	All	All	DT	B-NP
O	706	712	calves	calf	NNS	I-NP
O	713	717	were	be	VBD	B-VP
O	718	726	examined	examine	VBN	I-VP
O	727	732	daily	daily	JJ	B-NP
O	733	736	and	and	CC	I-NP
B-Organism_substance	737	742	fecal	fecal	JJ	I-NP
I-Organism_substance	743	750	samples	sample	NNS	I-NP
O	751	755	were	be	VBD	B-VP
O	756	765	collected	collect	VBN	I-VP
O	766	771	three	three	CD	B-NP
O	772	777	times	time	NNS	I-NP
O	778	779	a	a	DT	B-NP
O	780	784	week	week	NN	I-NP
O	785	788	for	for	IN	B-PP
O	789	798	detection	detection	NN	B-NP
O	799	802	and	and	CC	I-NP
O	803	814	enumeration	enumeration	NN	I-NP
O	815	817	of	of	IN	B-PP
O	818	821	the	the	DT	B-NP
O	822	831	nalidixic	nalidixic	JJ	I-NP
O	831	832	-	-	HYPH	I-NP
O	832	836	acid	acid	NN	I-NP
O	837	846	resistant	resistant	JJ	I-NP
O	847	848	E	E	NN	I-NP
O	848	849	.	.	.	O
O	850	854	coli	coli	NNP	B-NP
O	855	859	O157	O157	NNP	I-NP
O	859	860	.	.	.	O

O	861	865	Four	Four	CD	B-NP
O	866	871	weeks	week	NNS	I-NP
O	872	877	after	after	IN	B-PP
O	878	881	the	the	DT	B-NP
O	882	886	last	last	JJ	I-NP
O	887	891	calf	calf	NN	I-NP
O	892	899	stopped	stop	VBD	B-VP
O	900	908	shedding	shed	VBG	I-VP
O	908	909	,	,	,	O
O	910	913	all	all	DT	B-NP
O	914	920	calves	calf	NNS	I-NP
O	921	925	were	be	VBD	B-VP
O	926	936	necropsied	necropsie	VBN	I-VP
O	937	940	and	and	CC	O
B-Organism_substance	941	948	samples	sample	NNS	B-NP
O	949	953	from	from	IN	B-PP
O	954	957	the	the	DT	B-NP
B-Organism_subdivision	958	974	gastrointestinal	gastrointestinal	JJ	I-NP
I-Organism_subdivision	975	980	tract	tract	NN	I-NP
O	981	985	were	be	VBD	B-VP
O	986	991	taken	take	VBN	I-VP
O	992	995	for	for	IN	B-PP
O	996	999	the	the	DT	B-NP
O	1000	1009	detection	detection	NN	I-NP
O	1010	1012	of	of	IN	B-PP
O	1013	1016	the	the	DT	B-NP
O	1017	1026	nalidixic	nalidixic	JJ	I-NP
O	1026	1027	-	-	HYPH	I-NP
O	1027	1031	acid	acid	NN	I-NP
O	1032	1041	resistant	resistant	JJ	I-NP
O	1042	1043	E	E	NN	I-NP
O	1043	1044	.	.	.	O
O	1045	1049	coli	coli	NNP	B-NP
O	1050	1054	O157	O157	NNP	I-NP
O	1054	1055	.	.	.	O

O	1056	1069	Dexamethasone	Dexamethasone	NN	B-NP
O	1069	1070	-	-	HYPH	B-NP
O	1070	1078	injected	inject	VBN	I-NP
O	1079	1085	calves	calf	NNS	I-NP
O	1086	1090	shed	shed	VBN	B-VP
O	1091	1093	at	at	IN	B-PP
O	1094	1100	higher	high	JJR	B-NP
O	1101	1107	levels	level	NNS	I-NP
O	1108	1109	(	(	(	O
O	1109	1110	P	P	NN	B-NP
O	1111	1112	=	=	SYM	B-VP
O	1113	1114	0	0	CD	B-NP
O	1114	1115	.	.	SYM	I-NP
O	1115	1117	04	04	CD	I-NP
O	1117	1118	)	)	)	O
O	1119	1121	on	on	IN	B-PP
O	1122	1126	days	day	NNS	B-NP
O	1127	1128	4	4	CD	B-NP
O	1129	1132	and	and	CC	I-NP
O	1133	1134	7	7	CD	I-NP
O	1135	1150	postinoculation	postinoculation	NN	I-NP
O	1150	1151	,	,	,	O
O	1152	1155	but	but	CC	O
O	1156	1159	not	not	RB	O
O	1160	1170	thereafter	thereafter	RB	B-ADVP
O	1170	1171	.	.	.	O

O	1172	1176	None	None	NN	B-NP
O	1177	1179	of	of	IN	B-PP
O	1180	1183	the	the	DT	B-NP
B-Organism_substance	1184	1191	samples	sample	NNS	I-NP
O	1192	1201	collected	collect	VBN	B-VP
O	1202	1204	at	at	IN	B-PP
O	1205	1213	necropsy	necropsy	NN	B-NP
O	1214	1218	were	be	VBD	B-VP
O	1219	1227	positive	positive	JJ	B-ADJP
O	1228	1231	for	for	IN	B-PP
O	1232	1233	E	E	NN	B-NP
O	1233	1234	.	.	.	O
O	1235	1239	coli	coli	NNP	B-NP
O	1240	1244	O157	O157	NNP	I-NP
O	1244	1245	.	.	.	O

O	1246	1250	Data	Datum	NNS	B-NP
O	1251	1255	from	from	IN	B-PP
O	1256	1260	this	this	DT	B-NP
O	1261	1266	study	study	NN	I-NP
O	1267	1274	suggest	suggest	VBP	B-VP
O	1275	1279	that	that	IN	B-SBAR
O	1280	1285	there	there	EX	B-NP
O	1286	1289	may	may	MD	B-VP
O	1290	1292	be	be	VB	I-VP
O	1293	1294	a	a	DT	B-NP
O	1295	1299	time	time	NN	I-NP
O	1299	1300	-	-	HYPH	B-NP
O	1300	1309	dependent	dependent	JJ	I-NP
O	1310	1322	relationship	relationship	NN	I-NP
O	1323	1330	between	between	IN	B-PP
O	1331	1344	dexamethasone	dexamethasone	NN	B-NP
O	1345	1362	immunosuppression	immunosuppression	NN	I-NP
O	1363	1366	and	and	CC	O
O	1367	1370	the	the	DT	B-NP
B-Organism_substance	1371	1376	fecal	fecal	JJ	I-NP
O	1377	1390	concentration	concentration	NN	I-NP
O	1391	1393	of	of	IN	B-PP
O	1394	1395	E	E	NN	B-NP
O	1395	1396	.	.	.	O
O	1397	1401	coli	coli	NN	B-NP
O	1402	1406	O157	O157	NN	I-NP
O	1407	1410	but	but	CC	O
O	1411	1415	that	that	IN	B-SBAR
O	1416	1425	transient	transient	JJ	B-NP
O	1426	1443	immunosuppression	immunosuppression	NN	I-NP
O	1444	1448	does	do	VBZ	B-VP
O	1449	1452	not	not	RB	I-VP
O	1453	1459	appear	appear	VB	I-VP
O	1460	1462	to	to	TO	I-VP
O	1463	1470	prolong	prolong	VB	I-VP
O	1471	1479	shedding	shedding	NN	B-NP
O	1480	1482	of	of	IN	B-PP
O	1483	1484	E	E	NN	B-NP
O	1484	1485	.	.	.	O
O	1486	1490	coli	coli	NNP	B-NP
O	1491	1495	O157	O157	NNP	I-NP
O	1495	1496	.	.	.	O

